Kasivisvanathan Ramanathan, Abbassi-Ghadi Nima, Prout Jeremy, Clevenger Ben, Fusai Giuseppe K, Mallett Susan V
Department of Anaesthesia, Royal Free London NHS Foundation Trust, London, UK.
HPB (Oxford). 2014 Aug;16(8):768-75. doi: 10.1111/hpb.12222. Epub 2014 Jan 28.
The aim of this prospective observational study was to compare peri/post-operative outcomes of thoracic epidural analgesia (TEA) versus intrathecal morphine and fentanyl patient-controlled analgesia (ITM+fPCA) for patients undergoing a hepatic resection (HR).
Patients undergoing elective, one-stage, open HR for benign and malignant liver lesions, receiving central neuraxial block as part of the anaesthetic, in a high-volume hepato-pancreato-biliary unit, were included in the study. The primary outcome measure was post-operative length of stay (LoS).
A total of 73 patients (36 TEA and 37 ITM+fPCA) were included in the study. The median (IQR) post-operative LoS was 13 (11-15) and 11 (9-13) days in the TEA and ITM+fPCA groups, respectively (P = 0.011). There was significantly lower median intra-operative central venous pressure (P < 0.001) and blood loss (P = 0.017) in the TEA group, and a significant reduction in the time until mobilization (P < 0.001), post-operative intra-venous fluid/vasopressor requirement (P < 0.001/P = 0.004) in the ITM+fPCA group. Pain scores were lower at a clinically significant level 12 h post-operatively in the TEA group (P < 0.001); otherwise there were no differences out to day five. There were no differences in quality of recovery or postoperative morbidity/mortality between the two groups.
ITM+fPCA provides acceptable post-operative outcomes for HR, but may also increase the incidence of intra-operative blood loss in comparison to TEA.
这项前瞻性观察性研究的目的是比较接受肝切除术(HR)的患者采用胸段硬膜外镇痛(TEA)与鞘内注射吗啡和芬太尼患者自控镇痛(ITM+fPCA)的围手术期/术后结局。
本研究纳入了在一个大容量肝胰胆科单位接受择期、一期、开放性HR治疗良性和恶性肝脏病变且接受中枢神经阻滞作为麻醉一部分的患者。主要结局指标是术后住院时间(LoS)。
本研究共纳入73例患者(36例TEA组和37例ITM+fPCA组)。TEA组和ITM+fPCA组术后LoS的中位数(IQR)分别为13(11-15)天和11(9-13)天(P = 0.011)。TEA组术中中心静脉压中位数显著更低(P < 0.001),失血量也显著更低(P = 0.017),而ITM+fPCA组在活动时间(P < 0.001)、术后静脉输液/血管升压药需求方面显著降低(P < 0.001/P = 0.004)。TEA组术后12小时疼痛评分在临床显著水平更低(P < 0.001);否则直至术后第5天两组无差异。两组在恢复质量或术后发病率/死亡率方面无差异。
ITM+fPCA为HR提供了可接受的术后结局,但与TEA相比,可能也会增加术中失血的发生率。